BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Pre-Clinical
Celsion Corporation (CLSN) Announces Potent, Durable Preclinical Lung Expression Data For Its Novel TheraSilence RNA Program 5/21/2015
FDA Grants Orphan Drug Designation To Aura Biosciences’ Novel Treatment For Uveal Melanoma 5/21/2015
Zealand Pharma  (ZEAL.CO) Starts Clinical Development Of A Multiple-Dose Version Of Its Stable Glucagon Analogue, ZP4207 5/20/2015
Synthetic Biologics, Inc. (SYN)' SYN-004 Microbiome-Protecting Preclinical Data Highlighted In Late-Breaking Poster At Digestive Disease Week 2015 5/19/2015
Anavex (AVXL) Releases Promising Full Preclinical Epilepsy Data At Antiepileptic Drug Trials XIII Conference 5/18/2015
Synthetic Biologics, Inc. (SYN)' Novel SYN-010 Preclinical Data Featured In Digestive Disease Week Poster 5/18/2015
Celsion Corporation (CLSN) Announces Publication Of Preclinical Data Demonstrating Lung Specific Delivery of microRNA-145 Inhibitor Using Its Novel TheraSilence Platform 5/15/2015
Amarantus BioSciences, Inc. Announces Successful Delivery And Distribution Of MANF In Preclinical Model To Brain Areas Involved In Parkinson's Disease 5/15/2015
Arno Therapeutics Announces Preclinical Data Demonstrating Broad-Spectrum Antiviral Activity For AR-12 5/15/2015
Acucela Announces Publication Of Pre-clinical Data For Emixustat Hydrochloride 5/14/2015
Mesoblast (MSB.AX) Cell Therapy Reduces Inflammation And Reverses Coronary Artery Dysfunction In Rheumatoid Arthritis Preclinical Study 5/12/2015
Celgene (CELG) CEO: Partnerships Bear Fruit to Four New Compounds 5/12/2015
Isarna Therapeutics Presents Positive Preclinical Results Supporting Development Of ISTH0036 For The Treatment Of Glaucoma 5/11/2015
Novogen Limited (NVGN) Release: Australian Studies Confirm TRXE-009 Kills Resistant Paediatric Brain Cancer Cells 5/8/2015
FibroGen, Inc. (FGEN) Announces Receipt Of Milestone Payment From AstraZeneca PLC (AZN) For Successful Completion Of Long-Term Pre-Clinical Safety Studies Of Roxadustat 5/7/2015
Arrowhead Research Corporation (ARWR) Presents Data On Potential RNAi Candidate Targeting Factor 12 Mediated Angioedemic And Thromboembolic Diseases 5/7/2015
Aduro Biotech (ADRO)'s Preclinical Results For Its STING-Targeted CDN Immuno-Oncology Platform Highlighted In Prestigious Peer-Reviewed Publications 5/7/2015
PharmaCyte Biotech (NVLX)'s Melligen Cells Prove Safe In First Preclinical Test 5/6/2015
Dicerna (DRNA) Announces Potent, Durable Knockdown Of Gene Expression In Non-Human Primates With DsiRNA-EX Conjugates Being Investigated For Treatment Of Primary Hyperoxaluria Type 1 (PH1) 5/6/2015
Eleven Biotherapeutics (EBIO) Presents Data On EBI-031 For The Treatment Of Diabetic Macular Edema At Association for Research in Vision & Ophthalmology 2015 Annual Meeting 5/6/2015
MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) (MSHL)'s Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity In Combination With Tyrosine-Kinase Inhibitor In Pre-Clinical Studies 5/4/2015
Cell Cure Neurosciences Announces Preclinical Efficacy Data Demonstrating Opregen Preserves Vision 5/4/2015
Islet Sciences Publishes Data Supporting Remogliflozin Etabonate As A Potential Treatment For NAFLD And NASH 5/4/2015
Tamir Biotechnology, Inc. (Formerly Known as Alfacell Corporation) (ACEL) Provides Update On TMR004 Development Against Mutating Ebola 5/1/2015
Thetis Pharmaceuticals Presents Preclinical Data On Novel Oral Agent For Type 2 Diabetes 4/29/2015
EXCLUSIVE: Navidea (NAVB) CEO Tells BioSpace (DHX) New Cancer Treatment Will See More Trial Data in 2015 4/29/2015
Spring Bank Pharmaceuticals, Inc. Presents Preclinical And Clinical Data On Immunomodulatory Agent SB 9200 At The 2015 Annual Meeting Of The European Association For The Study Of The Liver 4/27/2015
Posters At ECCMID 2015 Highlight Preclinical Data From Synthetic Biologics' Novel SYN-005 Monoclonal Antibody Combination For The Treatment And Prophylaxis Of Whooping Cough (Pertussis) 4/27/2015
TAXIS Pharmaceuticals, Inc. Demonstrates Clinical Potential Of TXA709 In Combating Antibiotic Resistance 4/27/2015
Novira Therapeutics Announces Presentation Of Preclinical Antiviral Data For NVR 3-778 At EASL 4/27/2015
BioTime (BTX)’s Clinical Grade Stem Cells From Subsidiary ES Cell International To Be Used In Planned CIRM-Funded Preclinical Studies Of Huntington’s Disease 4/27/2015
Tolero Pharmaceuticals Presents Data Demonstrating Profound Synergy Of Alvocidib And Bromodomain Protein Inhibitors In Nonclinical Models Of Acute Myeloid Leukemia 4/27/2015
Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression In Models Of Hepatocellular Carcinoma 4/24/2015
AuraSense Therapeutics Announces Publication Of Preclinical Data Demonstrating Immuno-Modulation By Its Proprietary Spherical Nucleic Acid Platform 4/23/2015
Medivir AB (MVRBF): Positive Preclinical Antiviral And Safety Profile Of MIV-802 Supports Continued Development 4/23/2015
Cytori Therapeutics, Inc. (CYTX) Reports Preclinical And Mechanistic Data Supporting Use Of Cytori Cell Therapy In Wounds Combining Thermal Burn And Radiation Exposure 4/23/2015
Glide Technologies Completes Successful Proof-of-Concept Study With Novel Solid Dose Formulation of Teriparatide SDI 4/23/2015
TRANSGENE (ENX:TNG) Presents New Data With TG1050, An Immunotherapy Being Developed To Treat Chronic Hepatitis B, At The International Liver Congress 2015 4/23/2015
Threshold Pharmaceuticals, Inc. (THLD) Reports Preclinical Data Suggesting That TH-4000 May Overcome Resistance To Conventional EGFR Tyrosine Kinase Inhibitors 4/23/2015
PhaseBio Announces Promising Pre-Clinical Results For PB1046 In Models Of Duchenne Muscular Dystrophy 4/22/2015
Capricor Therapeutics, Inc. Granted FDA Orphan Drug Designation For Allogeneic Cardiosphere-Derived Cells For The Treatment Of Duchenne Muscular Dystrophy 4/22/2015
Deciphera Pharmaceuticals Presents Data Highlighting Kinase Inhibitor Pipeline Including Proprietary And Partnered Programs At AACR 2015 Annual Meeting 4/22/2015
Prescient Therapeutics Release: Encouraging Pre-Clinical Data Presented At U.S. Cancer Meeting 4/22/2015
Acetylon Pharmaceuticals Presents Data On Synergistic Activity Of Selective HDAC6 Inhibition In Preclinical Models Of Multiple Myeloma And Mantle Cell Lymphoma At The AACR Annual Meeting 4/22/2015
BIND Therapeutics (BIND) Presents Data Highlighting Ability Of Accurins To Control Biodistribution And Accumulate In Target Tissue At AACR Annual Meeting 2015 4/22/2015
Navidea Biopharmaceuticals (NAVB) Data For Manocept CD206 Targeting Platform Demonstrate Potential To Impact Tumor-Associated Macrophages And Kaposi’s Sarcoma Tumor Cells 4/22/2015
Curis, Inc. (CRIS) Presents Preclinical Data On CUDC-427 At AACR Annual Meeting 4/22/2015
Tekmira (TKMR) And Collaborators Publish Positive Preclinical Ebola Survival Data In Nature Journal 4/22/2015
Immunexcite Presents New Preclinical Data At AACR Demonstrating Ability Of Its Novel Cancer Immunotherapy Approach To Activate A Potent And Precise T-Cell Attack On Tumors 4/21/2015
OncoMed Pharmaceuticals, Inc. (OMED) Presents Data On Clinical And Preclinical Anti-Cancer Stem Cell Programs At AACR Annual Meeting 4/21/2015
Advaxis, Inc. Presents Lm-LLO Cancer Immunotherapy Data at the 2015 AACR Meeting 4/21/2015
Calithera Biosciences, Inc. (CALA) Highlights Results From Six Preclinical Abstracts At The AACR Annual Meeting 2015 4/21/2015
Preclinical Data Presented At AACR Demonstrate Synergistic Anti-Tumor Effects Of Peregrine Pharmaceuticals, Inc. (PPHM)'s Phosphatidylserine (PS)-Targeting Antibodies With Immune Checkpoint Inhibitors In Models Of Melanoma And Breast Cancer 4/21/2015
Vical Incorporated (VICL) Announces Presentation Of Preclinical Data For Congenital CMV DNA Vaccine At International Conference 4/21/2015
TetraLogic Pharmaceuticals (TLOG) Announces Publication Of Two Papers Describing Birinapant's Preclinical Activity In Chronic Hepatitis B 4/21/2015
Cantrixil Highly Successful In Preventing Growth Of Chemo-Resistant Ovarian Cancer 4/21/2015
Blend Therapeutics Presents Preclinical Data For Lead Candidate BTP-114 That Demonstrated Superiority To Cisplatin In Tumor Growth Inhibition 4/21/2015
Blend Therapeutics Presents Preclinical Data For Lead Pentarin™ Program, BTP-277, Demonstrating Specific And Potent Tumor Cell Targeting For Small-Cell Lung Cancer 4/21/2015
Ariad (ARIA) Announces Results Of Preclinical Studies On Brigatinib At The AACR Annual Meeting 4/21/2015
TRANSGENE (ENX:TNG) Presents New Pre-Clinical Data At AACR On (I) The Combination Of TG4010 With Immune Checkpoint Inhibitors; (Ii) TG3003, An Anti-CD115 Monoclonal Antibody 4/21/2015
Epizyme (EPZM) Presents Preclinical Research Providing Deeper Understanding Of Multiple Cancer Targets 4/20/2015
Rexahn Pharmaceuticals, Inc. (RNN) Identifies RX-3117 Biomarker & Presents Data At The 2015 AACR Annual Meeting 4/20/2015
Celldex (CLDX)'s Varlilumab Demonstrates Synergistic Anti-Tumor Activity With PD-1 Signaling Blockade In Preclinical Studies 4/20/2015
TG Therapeutics, Inc. (MHA) Presents Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting 4/20/2015
Imugene Limited (IMU.AX) Release: HER-Vaxx Re-Formulation Shows Dramatic Ten-Fold Increase In Antibodies And Early Onset Of Response; Additional Milestone Met 4/20/2015
Blueprint Medicines Presents New Preclinical Data Demonstrating Significant Anti-Tumor Activity Of BLU-285 In Treatment-Resistant GIST And On Novel Cancer Drug Targets 4/20/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Data At The 2015 AACR Annual Meeting 4/20/2015
NanoViricides, Inc. (NNVC.PK) Reports That Its Topical Anti-Herpes Treatment Dramatically Improves Clinical Symptoms In An Animal Model 4/20/2015
AVEO Oncology (AVEO) Announces Presentation Of AV-380 Preclinical Data In Cancer Associated Cachexia At 2015 Annual Meeting Of The AACR 4/20/2015
Pharmacyclics (PCYC) Release: Ibrutinib (IMBRUVICA) Improves OutcomesFor Pancreatic Ductal Adenocarcinoma In Mouse Models 4/20/2015
Acetylon Pharmaceuticals Announces Preclinical Anti-Cancer Activity Of Selective HDAC1/2 Inhibitors In Neuroblastoma And Acute Myeloid Leukemia 4/20/2015
DelMar Pharmaceuticals Presents Promising Preclinical Data On VAL-083's Potential To Treat Temozolomide-Resistant Glioblastoma Multiforme (GBM) 4/20/2015
Peloton Therapeutics Presents Promising Data On First Inhibitor Of HIF-2a For Renal Cell Carcinoma At 2015 AACR Annual Meeting 4/20/2015
Ligand Pharmaceuticals Inc. (LGND) Partner TG Therapeutics, Inc. (MHA) Presents Positive Pre-Clinical Data On IRAK4 Compounds At The AACR Annual Meeting 4/20/2015
Tokai Pharmaceuticals (TKAI) Announces Preclinical Results From The University of Maryland Showing Galeterone And Analogs Inhibit Pancreatic Cancer Cell Growth 4/20/2015
Mersana Therapeutics' Lead Fleximer Immunoconjugate Demonstrates Potent Activity In Low HER2-Expressing Tumor Models 4/17/2015
Peregrine Pharmaceuticals, Inc. (PPHM) Announces Three Abstracts Accepted For Presentation At American Association for Cancer Research 2015 Annual Meeting 4/16/2015
Debiopharm Announces Results Of 2 Key Oncology Programs At 2015 American Association for Cancer Research Conference 4/16/2015
Cerulean Pharma Inc. (CERU) Announces Three Posters To Be Presented With Preclinical CRLX101 Data At The American Association for Cancer Research Annual Meeting 4/16/2015
Rexahn Pharmaceuticals, Inc. (RNN) To Present Data On RX-3117 And Supinoxin At The 2015 American Association for Cancer Research Annual Meeting 4/13/2015
Alnylam (ALNY) And Collaborators Publish Pre-Clinical Study Results In Nature Medicine On ALN-AT3, An Investigational RNAi Therapeutic Targeting Antithrombin (AT) For The Treatment Of Hemophilia And Rare Bleeding Disorders (RBD) 4/13/2015
Cerulean Pharma Inc. (CERU) Announces Publication Showing CRLX101 Targets Breast Cancer Stem Cells And Impedes Resistance To Anti-Angiogenic Therapy In Preclinical Models 4/13/2015
ChromaDex, Inc. Release: Published Study Shows Topical Treatment With Pterostilbene Effectively Protects Hairless Mice Against UVB Radiation-Induced Skin Damage And Carcinogenesis 4/10/2015
Inovio Pharmaceuticals (INO) HPV Immunotherapy Activates Robust In Vivo T Cell Responses In Head & Neck Cancer Patients 4/9/2015
Anavex (AVXL) Encouraged By New Scientific Data Revealing Positive Role Of Sigma-1 Receptors In Brain Injuries 4/7/2015
Endonovo Therapeutics Targets Non-Invasive Treatment For Acute And Chronic Inflammatory Conditions Of The Liver 4/7/2015
Kite Pharma (KITE) Announces Publication In Science Of Cancer Immunotherapy Articles Authored By Lead Collaborators At The National Cancer Institute And The Netherlands Cancer Institute (NCI) 4/6/2015
Corbus Pharmaceuticals, Inc. Announces Presentation Of Positive Data On Anti-Fibrotic Effects Of Resunab In A Preclinical Model Of Lung Fibrosis At The Experimental Biology 2015 Scientific Conference 4/1/2015
BioBlast Pharma (ORPN) Announces Positive In Vivo Preclinical Proof-Of-Concept Results Of Its Cabaletta Platform In Spinocerebellar Ataxia Type 3 (SCA3) 3/30/2015
Calithera Biosciences, Inc. (CALA) Reports Fourth Quarter And Full Year 2014 Financial Results And Recent Highlights 3/27/2015
BioBlast Pharma (ORPN) Announces Positive Preclinical Proof-Of-Concept Results Of Its Novel Mitochondrial Protein Replacement Platform In Friedreich's Ataxia 3/26/2015
Tekmira (TKMR) Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of Apoc3 And ANGPTL3 Genes 3/26/2015
Genisphere's 3DNA Drug Delivery Platform Achieves Success In Preclinical Treatment Of Posterior Capsular Opacification (PCO) 3/26/2015
Arch Therapeutics Announces Favorable Preclinical Data From An Independent Study Of AC5 Surgical Hemostatic Device Versus A Popular Cellulose-Based Hemostatic Agent 3/25/2015
AvidBiotics Release: Study Published In mBio Shows That Avidocin Proteins Prevent Clostridium Difficile Infection In Mice Without Harming Protective Gut Bacteria 3/24/2015
New Data Supporting Arno Therapeutics' HDAC Inhibitor AR-42 Published In The Journal of Urology 3/24/2015
Conatus Pharmaceuticals Inc. And BioReliance Corporation Present Key Emricasan Preclinical Safety Results At Society Of Toxicology Annual Meeting 3/24/2015
Batu Biologics Publishes Preclinical Data For ValloVax 3/20/2015
Kineta Inc.’s SHK-186 Shows Encouraging Early Results As Potential Therapy For Autoimmune Eye Diseases 3/19/2015
Assay Depot, Inc. Creates Preclinical Innovation Marketplace For AstraZeneca PLC (AZN) 3/19/2015
Sangui BioTech International Inc. (SGBI): Series Of Preclinical Trials Concluded Successfully 3/18/2015
Blueprint Medicines Publishes Preclinical Proof-Of-Concept Data On Promising New Therapy For Patients With Genomically Defined Hepatocellular Carcinoma 3/16/2015
Synthetic Biologics, Inc. (SYN) Reports Year End 2014 Financial Results And Operational Highlights 3/16/2015
BioLineRx Ltd.’s Treatment for Type 1 Diabetes Effective In Preclinical Trials 3/11/2015
Greenovation Biotech GmbH Successfully Completes Preclinical Toxicology Studies Of Alpha - Galactosidase 3/10/2015
Regeneus (RGS.AX) (ASX:RGS) Positive Preclinical Results For Progenza 3/9/2015
Biothera's Investigational Cancer Immunotherapy Imprime PGG Neutralizes Cancer Defense Mechanisms In The Tumor Mircoenvironment 3/9/2015
Horizon Pharma plc.  (HZNP) Announces That Pre-Clinical Data Show Treatment With Interferon Gamma Improved Signs Of Disease Severity Of Rare Bone Disease 3/9/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015
N8 Medical Release: Recently Published Study Demonstrates That CSA-90 May Promote Osteogenesis And Prevent Staphylococcus Aureus Infection In Preclinical Models 3/4/2015
Sirona Biochem: Positive Preclinical Toxicology Results For Its SGLT2 Inhibitor Trigger Milestone Payment From Wanbang Biopharmaceuticals 3/4/2015
CohBar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-c And Its Role In Metabolic Regulation 3/4/2015
Momenta Pharmaceuticals, Inc. (MNTA) Announces Publication Revealing Development Of A Novel Process To Generate High-Quality Hyper-Sialylated IVIg Drug Candidate In PNAS 3/3/2015
CohBar Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation 3/3/2015
Pharmacyclics (PCYC) Release: In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3/2/2015
Cohbar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation 3/2/2015
Alkermes plc (ALKS) Announces New Drug Candidate, ALKS 7119, For Treatment Of Alzheimer's Agitation, Depression And Other CNS Diseases 3/2/2015
Gilead (GILD) Announces Preclinical Data For An Investigational TLR7 Agonist In SIV-Infected, Virally Suppressed Monkeys 2/26/2015
Bayer HealthCare (BAY) Strikes Deal With Mission Bay Incubator Tenant Aronora 2/25/2015
Lixte Biotechnology's Lead Compound Reported To Be Active Against Hematologic Cancers In Pre-Clinical Studies 2/25/2015
Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm Therapeutics (KPTI)'s SINE Compounds In The Treatment Of Multiple Sclerosis 2/24/2015
Celsion Corporation (CLSN) Presents Clinical And Preclinical Data For GEN-1 IL-12 Immunotherapy In Ovarian Cancer At The Molecular Medicine TRI-Conference 2/20/2015
Pharmacyte Biotech Initiates Expanded Follow-Up Study In The United States On The Accumulation Of Malignant Ascites Fluid 2/19/2015
Addex Therapeutics (ADXN.SW) mGluR2 NAM Demonstrates Protection In Preclinical Model Of Ischemic Neuronal Death 2/19/2015
Vaccinex, Inc. Announces The Publication Of Data Demonstrating Preclinical Efficacy In An Animal Model Of Huntington Disease 2/18/2015
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015
Anatara Lifesciences Reports Successful DetachTM Trial Results 2/18/2015
Aerie Pharmaceuticals, Inc. (AERI) Announces Potential Breakthroughs With New Preclinical Research 2/18/2015
Halozyme Therapeutics, Inc. (HALO) Announces Preclinical Study Results Of Pegph20 Published In Molecular Cancer Therapeutics 2/17/2015
Tiny Startup Spyryx Looks to One-Up Vertex Pharmaceuticals (MA) (VRTX) With One-Size-Fits-All Cystic Fibrosis Therapy 2/13/2015
Despite CEO's Comments, Experimental Sarepta (SRPT) Drug Protects Lab Monkeys From Ebola 2/11/2015
12635 E. Montview Blvd. Release: Preclinical Melioidosis Results Presented At The 2015 ASM Biodefense And Emerging Diseases Research Meeting In Washington, DC 2/11/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs 2/11/2015
Heat Biologics Presents Positive Preclinical Data On A Novel Approach To Combination Immunotherapy At The Keystone Symposia On Tumor Immunology 2/11/2015
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015 2/10/2015
Amicus Therapeutics, Inc. (FOLD) Presents Preclinical Data On Next-Generation Pompe ERT At Worldsymposium 2015 2/10/2015
Two of Roche (RHHBY)'s Experimental Parkinson's Drugs Caused Lung Toxicity in Monkeys 2/9/2015
Anavex (AVXL) Confirms Positive Preclinical Epilepsy Data For ANAVEX 2-73 - Validation As Potential Platform Drug For Multiple Neurodegenerative Diseases 2/9/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces The Publication Of Preclinical Data For Supinoxin (RX-5902) Demonstrating Mechanism Of Action 2/9/2015
Hemispherx Biopharma (HEB) Posts USAMRIID Ebola Study Concluding Ampligen Produced 100% Survival Rate In Rodents With 100% Mortality In Placebo 2/9/2015
VBL Therapeutics (VBLX) To Present Preclinical Data At Keystone Symposium On Liver Metabolism And Nonalcoholic Fatty Liver Disease 2/9/2015
Lycera Announces Research Showing Promising Anti-Cancer Activity Of Novel, Oral Immunotherapy Candidates 2/9/2015
Hemispherx Biopharma (HEB): US Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate In Ebola Virus Rodent Study 2/2/2015
Pharmacyte Biotech Initiates First Preclinical Study Of Its Encapsulated Cell Product For Novel Treatment Of Diabetes 2/2/2015
The Journal Diabetes Publishes Pre-Clinical Data On Cortendo’s Novel Diabetes Treatment, BP-2001 1/28/2015
Can-Fite BioPharma (CFBI)'s CF602 Demonstrates Efficacy In Treatment Of Sexual Dysfunction In Preclinical Studies 1/27/2015
Vaccinex, Inc. Announces Groundbreaking Preclinical Data Demonstrating An Immunomodulatory Role For Anti-SEMA4D Antibody Blockade In Colon And Breast Cancer 1/27/2015
BrainStorm Cell Therapeutics Inc. Announces Exceptional Preclinical Results Of Nurown™ In Mouse Autism Model 1/26/2015
MYOS (MYOS)'s Preclinical Study Of Fortetropin's™ Mechanism Of Action Demonstrate Regulatory Effects On Three Key Muscle Health Pathways 1/26/2015
RestorGenex Announces Presentation Of Scientific Data On RES-529 For The Treatment Of Glioblastoma At Keystone Symposia On PI 3-Kinase Signaling Pathway 1/23/2015
Peer-Reviewed Glioma Surgery Study With Cellectar Biosciences  (NVLT) Fluorescence Cancer-Targeting Agents Chosen For The Cover Of Neurosurgery 1/22/2015
Dry Eye Syndrome: Neuroptis Biotech Successfully Completes The Pre-Clinical Phase For ML7 1/21/2015
PsychoGenics Inc. Obtains A License To The McGill Universityl-R-Thy1-APP Rat Model Of Alzheimer’s Disease 1/21/2015
Karcinolys’ Myb34.5 Oncolytic Virus Preclinical Results In Pancreatic Cancer Featured In Peer-Reviewed Journal "Human Gene Therapy" 1/21/2015
Verastem, Inc. (VSTM) Announces Publication Of Scientific Data For VS-5584 In Cancer Research 1/16/2015
Hemispherx Biopharma (HEB) Release: Low Natural Killer (NK) Activity Observed Across The Chronic Fatigue Syndrome (CFS) Disease Spectrum 1/12/2015
Dicerna Pharmaceuticals (DRNA) Presents Positive Preclinical Data On Its DsiRNA Therapeutics Targeting MYC And ?-Catenin At American Association for Cancer Research MYC: From Biology To Therapy Meeting 1/12/2015
PHARNEXT's Pleotherapy Shows Synergistic Effects With PXT-864 In Alzheimer's Disease Through Preclinical Data Published In Nature's Scientific Reports 1/8/2015
Bio-Path Holdings, Inc. (BPTH)’ Liposomal Grb-2 Featured In Peer-Reviewed Journal “Expert Opinion On Drug Delivery” 1/7/2015
Minerva Neurosciences, Inc. (NERV) Reports Positive Data Showing An Analog Of Minerva's MIN-301 Compound Improves Symptoms Of Parkinson's Disease In Primates 1/6/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces Publication Of Preclinical Data For RX-3117 Demonstrating Effectiveness Against Gemcitabine Resistant Human Cancer Cells 1/6/2015
Novartis AG (NVS) Researchers Claim to Have Discovered "Fountain of Youth" Drug 1/5/2015
Biocryst Pharmaceuticals (BCRX) Announces Study Results For BCX4430 In A Non-Human Primate Model Of Ebola Virus Infection 12/23/2014
Bio-Path Holdings, Inc. (BPTH) To Initiate Development Of Liposomal Bcl-2 In Follicular Lymphoma 12/22/2014
Medivir AB (MVRBF): MIV-802 Has Been Selected As A Candidate Drug And Enters Non-Clinical Development For The Treatment Of Hepatitis C Infection 12/22/2014
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I 12/19/2014
Canopus BioPharma, Inc. Announces Positive Results From An In-Vitro Live Ebola Virus Study 12/19/2014
Nuvilex (NVLX) Provides Shareholder Update On Cancer And Diabetes Programs 12/16/2014
Novogen Limited (NVGN) Announces Breakthrough Discovery In The Treatment Of Melanoma 12/16/2014
Vaccinex, Inc. Announces Publication Of Preclinical Studies With An Anti-SEMA4D Antibody In Animal Models Of Neuroinflammatory And Demyelinating Disease 12/12/2014
Enzyme Bio-Systems Ltd. Release: Preclinical Xenograft Studies Show Positive Results For Amooranin 12/11/2014
Syros Pharmaceuticals Announces New Research Published On CDK7 In Lung And Pediatric Cancers 12/11/2014
NIH Publishes Results Of Preclinical Collaboration With ChromaDex, Inc. Showing Potential Benefit Of Nicotinamide Riboside 12/10/2014
Celator Pharmaceuticals, Inc. Presents Data On CPX-351 At The 56th American Society of Hematology Annual Meeting 12/10/2014
Kadmon Corporation Presents Preclinical Data On KD025 In Chronic Graft-Versus-Host-Disease At American Society of Hematology Annual Meeting 12/10/2014
Aptose Biosciences Presents APTO-253 Preclinical Data At 56th American Society of Hematology Annual Meeting 12/9/2014
Fate Therapeutics (FATE) Highlights Effects Of Nutrient-Rich Media On Ex Vivo Programmed CD34+ Cells Sourced From Umbilical Cord Blood 12/9/2014
GlycoMimetics, Inc. (GLYC) Highlights Potential Therapeutic Benefits Of Its Novel E-Selectin Antagonist At 56th American Society of Hematology Annual Meeting 12/9/2014
Epizyme (EPZM) First-In-Class PRMT5 Inhibitor Demonstrates In Vitro And In Vivo Activity In Models Of Mantle Cell Lymphoma 12/9/2014
Fate Therapeutics (FATE) Unveils Preclinical Findings Of Newly-Identified Small Molecule Modulator Combination For Ex Vivo Programming Of Mobilized Peripheral Blood 12/8/2014
Blueprint Medicines Debuts Comprehensive Preclinical Data Set On First Selective Drug For Patients With Systemic Mastocytosis At 2014 American Society of Hematology Annual Meeting 12/8/2014
Geron Corporation (GERN) Announces Publication Of Preclinical Data On Imetelstat Activity In Acute Myelogenous Leukemia 12/8/2014
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014
Aduro Biotech Announces Preclinical Data Presented At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/4/2014
Xenetic Biosciences Announces OncoHist™ Preclinical Data To Be Featured In A Poster Presentation At The American Society of Hematology Annual Meeting 12/4/2014
ARMGO Pharma Inc. And Servier Announce Advancement Of Rycal ARM210/S48168 Into Clinical Stage Program Targeting Duchenne Muscular Dystrophy 12/4/2014
ZIOPHARM Oncology, Inc. (ZIOP.OB) And Intrexon Corporation Present Clinical And Preclinical Data From Immuno-Oncology Programs At Intrexon Corporation Tumor Immunology And Immunotherapy Meeting 12/4/2014
Idera Pharmaceuticals, Inc. (IDRA) Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent And Systemic Anti-Tumor Activity In Preclinical Models 12/3/2014
Preclinical Data Published On AM-Pharma Holding BV’s recAP To Treat Ultra Rare Disease Hypophosphatasia 12/2/2014
AB Science (AB.PA) Advances Ultra-Selective SYK Kinase Inhibitor Into Full Preclinical Development 12/1/2014
Antibe Therapeutics Inc. Provides Update On Its Acute Pain Drug ATB-352 11/25/2014
Luoxis Announces Presentation Of Multiple Studies Validating Redoxsys As A Rapid And Non-Invasive Means Of Assessing Oxidative Stress 11/24/2014
Inovio Pharmaceuticals (INO) Melanoma DNA Immunotherapy Inhibits Tumor Growth And Increases Survival In Preclinical Study 11/20/2014
Nektar Therapeutics (CA) (NKTR) Presents Preclinical Study Findings For Etirinotecan Pegol (NKTR-102) In Combination With A PARP Inhibitor In BRCA1-Deficient Cancer Model 11/20/2014
Kolltan Pharmaceuticals Inc. Presents KTN3379 Clinical And Preclinical Data At International Cancer Meeting 11/20/2014
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-2701), An Advanced Multi-Targeted Kinase Inhibitor, At 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/20/2014
Cardioxyl Pharmaceuticals HNO Prodrugs Show Effectiveness In Preclinical Models Following Oral Administration, Improve Hemodynamics In Chronic Diastolic Dysfunction 11/20/2014
Nuvilex (NVLX) Announces Preliminary Data From Preclinical Study of Effects of Its Pancreatic Cancer Treatment on Ascites Fluid Formation 11/19/2014
Kadmon Corporation Presents Preclinical Data On Bi-Functional Anti-PD-L1/IL-15 Fusion Protein At EORTC-NCI-AACR Symposium 11/19/2014
Arch Therapeutics Reports Positive Preclinical Data From Study of AC5 Surgical Hemostatic Device™ In Animals Treated With Brilinta® (ticagrelor) 11/18/2014